HomeCompareHDRVX vs JNJ

HDRVX vs JNJ: Dividend Comparison 2026

HDRVX yields 7.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HDRVX wins by $13.1K in total portfolio value
10 years
HDRVX
HDRVX
● Live price
7.60%
Share price
$18.46
Annual div
$1.40
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.1K
Annual income
$1,230.38
Full HDRVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HDRVX vs JNJ

📍 HDRVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHDRVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HDRVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HDRVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HDRVX
Annual income on $10K today (after 15% tax)
$646.05/yr
After 10yr DRIP, annual income (after tax)
$1,045.82/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HDRVX beats the other by $342.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HDRVX + JNJ for your $10,000?

HDRVX: 50%JNJ: 50%
100% JNJ50/50100% HDRVX
Portfolio after 10yr
$26.5K
Annual income
$1,029.08/yr
Blended yield
3.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HDRVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HDRVX buys
0
JNJ buys
0
No recent congressional trades found for HDRVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHDRVXJNJ
Forward yield7.60%3.36%
Annual dividend / share$1.40$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$33.1K$20.0K
Annual income after 10y$1,230.38$827.78
Total dividends collected$10.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HDRVX vs JNJ ($10,000, DRIP)

YearHDRVX PortfolioHDRVX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,460$760.06$10,676$355.77+$784.00HDRVX
2$13,076$814.05$11,407$389.39+$1.7KHDRVX
3$14,860$868.09$12,198$426.53+$2.7KHDRVX
4$16,822$921.95$13,056$467.62+$3.8KHDRVX
5$18,975$975.41$13,987$513.12+$5.0KHDRVX
6$21,331$1,028.27$14,998$563.56+$6.3KHDRVX
7$23,905$1,080.35$16,098$619.52+$7.8KHDRVX
8$26,710$1,131.48$17,295$681.69+$9.4KHDRVX
9$29,761$1,181.53$18,599$750.82+$11.2KHDRVX
10$33,075$1,230.38$20,022$827.78+$13.1KHDRVX

HDRVX vs JNJ: Complete Analysis 2026

HDRVXStock

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of dividend-producing equity securities. The fund generally invests in a core group of 40-60 equity securities, including common stocks, preferred stocks, depository receipts, and other equity-related securities. It primarily invests in equity securities of companies that are economically tied to countries outside of the United States, including investments in emerging markets.

Full HDRVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HDRVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HDRVX vs SCHDHDRVX vs JEPIHDRVX vs OHDRVX vs KOHDRVX vs MAINHDRVX vs ABBVHDRVX vs MRKHDRVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.